Expanding Buprenorphine Use in Primary Care: Changing the Culture

dc.contributor.authorLeiser, Abraham
dc.contributor.authorRobles, Maria
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2023-09-26T14:15:56Z
dc.date.available2023-09-26T14:15:56Z
dc.date.issued2022
dc.eprint.versionFinal published version
dc.identifier.citationLeiser A, Robles M. Expanding Buprenorphine Use in Primary Care: Changing the Culture. Perm J. 2022;26(2):177-180. doi:10.7812/TPP/21.203
dc.identifier.urihttps://hdl.handle.net/1805/35799
dc.language.isoen_US
dc.publisherThe Permanente Federation
dc.relation.isversionof10.7812/TPP/21.203
dc.relation.journalThe Permanente Journal
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectAddiction
dc.subjectBuprenorphine
dc.subjectOpioid agonist therapy
dc.subjectOpioid use disorder
dc.subjectPrimary care
dc.subjectSubstance use disorder
dc.titleExpanding Buprenorphine Use in Primary Care: Changing the Culture
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662249/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
tpp_21.203.pdf
Size:
78.19 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: